These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15972487)

  • 1. Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli.
    Hunstad DA; Justice SS; Hung CS; Lauer SR; Hultgren SJ
    Infect Immun; 2005 Jul; 73(7):3999-4006. PubMed ID: 15972487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturation of intracellular Escherichia coli communities requires SurA.
    Justice SS; Lauer SR; Hultgren SJ; Hunstad DA
    Infect Immun; 2006 Aug; 74(8):4793-800. PubMed ID: 16861667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5.
    Acharya D; Sullivan MJ; Duell BL; Goh KGK; Katupitiya L; Gosling D; Chamoun MN; Kakkanat A; Chattopadhyay D; Crowley M; Crossman DK; Schembri MA; Ulett GC
    mSphere; 2019 Nov; 4(6):. PubMed ID: 31776239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli.
    Billips BK; Forrestal SG; Rycyk MT; Johnson JR; Klumpp DJ; Schaeffer AJ
    Infect Immun; 2007 Nov; 75(11):5353-60. PubMed ID: 17724068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism.
    Schilling JD; Mulvey MA; Vincent CD; Lorenz RG; Hultgren SJ
    J Immunol; 2001 Jan; 166(2):1148-55. PubMed ID: 11145696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder.
    Billips BK; Schaeffer AJ; Klumpp DJ
    Infect Immun; 2008 Sep; 76(9):3891-900. PubMed ID: 18559433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uropathogenic Escherichia coli dominantly suppress the innate immune response of bladder epithelial cells by a lipopolysaccharide- and Toll-like receptor 4-independent pathway.
    Hilbert DW; Pascal KE; Libby EK; Mordechai E; Adelson ME; Trama JP
    Microbes Infect; 2008 Feb; 10(2):114-21. PubMed ID: 18248759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
    Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.
    Mulvey MA; Schilling JD; Hultgren SJ
    Infect Immun; 2001 Jul; 69(7):4572-9. PubMed ID: 11402001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIGIRR participates in negative regulation of LPS response and tolerance in human bladder epithelial cells.
    Li D; Zhang X; Chen B
    BMC Immunol; 2015 Dec; 16():73. PubMed ID: 26634342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine receptor expression in Escherichia coli-infected and cytokine-stimulated human urinary tract epithelial cells.
    Säve S; Mjösberg J; Poljakovic M; Mohlin C; Persson K
    BJU Int; 2009 Dec; 104(11):1758-65. PubMed ID: 19466942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uropathogenic Escherichia coli Express Type 1 Fimbriae Only in Surface Adherent Populations Under Physiological Growth Conditions.
    Stærk K; Khandige S; Kolmos HJ; Møller-Jensen J; Andersen TE
    J Infect Dis; 2016 Feb; 213(3):386-94. PubMed ID: 26290608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon.
    Rafsanjany N; Senker J; Brandt S; Dobrindt U; Hensel A
    J Agric Food Chem; 2015 Oct; 63(40):8804-18. PubMed ID: 26330108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of uropathogenic Escherichia coli: role of outer membrane protein T and the mechanism].
    Qu Y; He X; Wang Q; Zhang L; Long M; Luo J; Zhang W; Cao H
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):174-9. PubMed ID: 24589591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triclosan inhibits uropathogenic Escherichia coli-stimulated tumor necrosis factor-alpha secretion in T24 bladder cells in vitro.
    Elwood CN; Chew BH; Seney S; Jass J; Denstedt JD; Cadieux PA
    J Endourol; 2007 Oct; 21(10):1217-22. PubMed ID: 17949329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uropathogenic Escherichia coli Engages CD14-Dependent Signaling to Enable Bladder-Macrophage-Dependent Control of Acute Urinary Tract Infection.
    Carey AJ; Sullivan MJ; Duell BL; Crossman DK; Chattopadhyay D; Brooks AJ; Tan CK; Crowley M; Sweet MJ; Schembri MA; Ulett GC
    J Infect Dis; 2016 Feb; 213(4):659-68. PubMed ID: 26324782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolin decreases the attachment, invasion and cytotoxicity of UPEC in bladder epithelial cells and inhibits UPEC biofilm formation.
    Shen XF; Ren LB; Teng Y; Zheng S; Yang XL; Guo XJ; Wang XY; Sha KH; Li N; Xu GY; Tian HW; Wang XY; Liu XK; Li J; Huang N
    Food Chem Toxicol; 2014 Oct; 72():204-11. PubMed ID: 25051393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uropathogenic Escherichia coli alters muscle contractions in rat urinary bladder via a nitric oxide synthase-related signaling pathway.
    Weng TI; Chen WJ; Wu HY; Liu SH
    J Infect Dis; 2006 Dec; 194(12):1774-82. PubMed ID: 17109352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection.
    Duell BL; Carey AJ; Tan CK; Cui X; Webb RI; Totsika M; Schembri MA; Derrington P; Irving-Rodgers H; Brooks AJ; Cripps AW; Crowley M; Ulett GC
    J Immunol; 2012 Jan; 188(2):781-92. PubMed ID: 22184725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.